fbpx

List – 56 Drug Patents that are Expiring between 2020 to 2022

Which drug patents are expiring in 2020?

There are about a dozen websites on the internet answering this very question. We can definitely do better than that. How about the list of drugs that are going off-patent within the next 3 years? Much better.  How can we make it even better, say for generic companies?

With the huge growth in the generic drug market, there is no doubt that generic companies (hey there!) are searching for drugs with a soon-to-be-expired label. To make their (your) work easy, we collected not just the drug names, but also included other information like yearly sales, treatment, ingredients, and the disease they cure which could help them (you) easily choose a drug most profitable to develop a generic version. 

Without any delay, here is the list of drugs. Thank us later!

Patents Expiring in 2020

Atrovant HFA
Ipratropium Bromide

Sales:
$135 million (2014)

More information about this Drug

Patents Expiration Date
US6739333 May 26, 2020
US6983743 May 26, 2020

Dosage : Aerosol, Metered; Inhalation
Company : Boehringer Ingelheim Pharmaceuticals Inc
Ingredients : Ipratropium Bromide
Treatment : Chronic Obstructive Pulmonary Disease and Asthma
ANDA Filing Company : – 

Byduredon BCISE
Exenatide

Sales:
$283 million (H1,2019)

More information about this Drug

Patents Expiration Date
US6414126 October 04, 2020
US6479065 August 10, 2020
US6515117 October 04, 2020
US6667061 May 25, 2020
US6872700 January 14, 2020
US6936590 October 04, 2020
US9198925 October 04, 2020

Dosage : Suspension, Extended Release, Subcutaneous
Company : Astrazeneca Ab
Ingredients : Exenatide
Treatment : Type 2 Diabetes Mellitus
ANDA Filing company : –

Chantix
Varenicline

Sales:
$1.08 billion (2018)

More information about this Drug

Patents Expiration Date
US6410550 November 10, 2020

Dosage : Tablet; Oral
Company : Pfizer
Ingredients : Varenicline Tartrate
Treatment : Smoking Cessation
ANDA Filing Companies : Mylan, Ajanta Pharma, Par Pharma, Apotex

Dexilant
Dexlansoprazole

Sales:
$445 Million (2017)

More information about this Drug

Patents Expiration Date
US6462058 December 15, 2020
US6939971 December 15, 2020
US7285668 December 15, 2020
US9145389 June 15, 2020

Dosage : Capsule, Delayed Release; Oral
Company : Takeda Pharmaceuticals Usa Inc
Ingredients : Dexlansoprazole
Treatment : Erosive Esophagitis
ANDA Filing Companies : Dr Reddy’s, Impax, Anchen, Twi Pharma

Inlyta
Axitinib

Sales:
$339 million (2017)

More information about this Drug

Patents Expiration Date
US7141581 June 30, 2020

Dosage : Tablet; Oral
Company : Pfizer
Ingredients : Axitinib
Treatment : Advanced Renal Cell Carcinoma
ANDA Filing Companies : Apotex, Glenmark

Safyral
Drospirenone; Ethinyl Estradiol; Levomefolate

Sales:
$22 million (2017)

More information about this Drug

Patents Expiration Date
US6441168 April 17, 2020

Dosage : Tablet; Oral
Company : Bayer Healthcare Pharmaceuticals Inc
Ingredients : Drospirenone; Ethinyl Estradiol; Levomefolate Calcium
Treatment : Oral Contraceptive
ANDA Filing Companies : Lupin, Watson

Saphris
Asenapine

Sales:
$139.7 million (2018)

More information about this Drug

Patents Expiration Date
US5763476 December 09, 2020

Dosage : Tablet; Sublingual
Company : Allergan Llc
Ingredients : Asenapine Maleate
Treatment : Antipsychotic
ANDA Filing Companies : Alembic, Amneal, Breckenridge, Hikma, SigmaPharma

Silenor
Doxepin

Sales:
$22.3 million (2017)

More information about this Drug

Patents Expiration Date
US6211229 February 17, 2020

Dosage : Tablet; Sublingual
Company : Currax Pharmaceuticals Llc
Ingredients : Doxepin Hydrochloride
Treatment : Sleep Problem (Insomnia)
ANDA Filing Companies : Par Pharma, Actavis, Mylan, Zydus Cadila

Sprycel
Dasatinib

Sales:
$536 million (2018)

More information about this Drug

Patents Expiration Date
US6596746 December 28, 2020
US7125875 October 13, 2020
US7153856 October 28, 2020

Dosage : Tablet; Oral
Company : Bristol Myers Squibb Co
Ingredients : Dasatinib
Treatment : Cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL
ANDA Filing Companies : Apotex, Dr Reddy’s

Vigamox
Moxifloxacin

Sales:
$267.9 million (2017)

More information about this Drug

Patents Expiration Date
US6716830 March 29, 2020
US7671070 March 29, 2020

Dosage : Solution/Drops; Ophthalmic
Company : Novartis Pharmaceuticals Corp
Ingredients : Moxifloxacin Hydrochloride
Treatment : Bacterial Conjunctivitis
ANDA Filing Companies : Teva, Watson, Lupin, Apotex, Aurobindo, Akorn, Alembic

Xarelto
Rivaroxaban

Sales:
$6.58 billion (2018)

More information about this Drug

Patents Expiration Date
US7585860 December 11, 2020
US7592339 December 11, 2020

Dosage : Tablet; Oral
Company : Janssen Pharmaceuticals Inc
Ingredients : Rivaroxaban
Treatment : Stroke and systemic embolism with nonvalvular atrial fibrillation
ANDA Filing Companies : Aurobindo, Breckenridge, Microlabs, Mylan, SigmaPharma, Torrent, Prinston Pharma, Sun (Taro), Teva, Alembic, Invagen, Lupin, Macleods, Accord (Intas), Hec Pharma

Patents Expiring in 2021

Bystolic
Nebivolol

Sales:
$585.8 million (2018)

More information about this Drug

Patents Expiration Date
US6545040 December 17, 2021

Dosage : Tablet; Oral
Company : Allergan Llc
Ingredients : Nebivolol Hydrochloride
Treatment : Hypertension
ANDA Filing Companies : Amerigen Pharma, Glenmark, Hetero, Torrent, Watson, Alkem, Aurobindo

Crixivan
Indinavir

Sales:

More information about this Drug

Patents Expiration Date
US6689761 February 10, 2021

Dosage : Capsule; Oral
Company : Merck Sharp And Dohme Corp
Ingredients :  Indinavir Sulfate
Treatment : HIV
ANDA Filing company :

Emtriva
Emtricitabine

Sales:
$15 million (2018)

More information about this Drug

Patents Expiration Date
US6642245 May 04, 2021
US6703396 September 09, 2021

Dosage : Capsule; Oral
Company : Gilead Sciences Inc
Ingredients : Emtricitabine
Treatment : Combination with other antiretroviral agents, for the treatment of HIV-1 infection
ANDA Filing Companies : Cipla, Aurobindo

Hysingla ER
Hydrocodone er

Sales:
$447 million (2017)

More information about this Drug

Patents Expiration Date
US6733783 October 30, 2021
US8361499 October 30, 2021
US8551520 October 30, 2021
US8647667 October 30, 2021

Dosage : Tablet, Extended Release; Oral
Company : Purdue Pharma Lp
Ingredients : Hydrocodone Bitartrate
Treatment : Severe Pain, Opioid (narcotic) Analgesics
ANDA Filing Companies : Alvogen,  Mylan

Perforomist
Formoterol

Sales:

More information about this Drug

Patents Expiration Date
US6667344 June 22, 2021
US6814953 June 22, 2021
US7348362 June 22, 2021
US7462645 June 22, 2021
US8623922 June 22, 2021
US9730890 June 22, 2021

Dosage : Solution; Inhalation
Company : Mylan Specialty Lp
Ingredients : Formoterol Fumarate
Treatment : Chronic Obstructive Pulmonary Disease including Chronic Bronchitis and Emphysema
ANDA Filing Company : Teva

Sutent
Sunitinib

Sales:
$264 million (2018)

More information about this Drug

Patents Expiration Date
US6573293 August 15, 2021
US7125905 August 15, 2021
US7211600 June 22, 2021

Dosage : Capsule; Oral
Company : Pfizer
Ingredients : Sunitinib Malate
Treatment : Cancer (kidney, pancreas, and intestinal)
ANDA Filing Company : Mylan

Zomig ns
Zolmitriptan

Sales:
$43.1 million (2018)

More information about this Drug

Patents Expiration Date
US6750237 May 28, 2021
US7220767 May 28, 2021

Dosage : Spray; Nasal
Company : Astrazeneca Pharmaceuticals Lp
Ingredients : Zolmitriptan
Treatment : Migraine
ANDA Filing Companies : Lannett, Par Pharma

Patents Expiring in 2022

Januvia
Sitagliptin

Sales:
$3.68 billion (2018)

More information about this Drug

Patents Expiration Date
US6699871 July 26, 2022
US7125873 July 26, 2022

Dosage : Tablet; Oral
Company : Merck Sharp And Dohme Corp
Ingredients : Sitagliptin Phosphate
Treatment : Type 2 Diabetes Mellitus
ANDA Filing Companies : Apotex, Mylan, Sandoz, Sun Pharma, Teva, Watson, Zydus Cadila

Pristiq
Desvenlafaxine

Sales:
$206 million (2018)

More information about this Drug

Patents Expiration Date
US6673838 March 01, 2022

Dosage : Tablet, Extended Release; Oral
Company : Pfizer
Ingredients : Desvenlafaxine Succinate
Treatment : Major Depressive Disorder
ANDA Filing Companies : Anchen, Apotex, Dr Reddy’s, Lupin,  Mylan,  Roxane, Sandoz,  Teva, Watson, Intelli Pharma, Wockhardt, Zydus Cadila, Alembic (Breckenridge)

Vimovo
Esomeprazole/Naproxen

Sales:
$67.6 million (2018)

More information about this Drug

Patents Expiration Date
US8557285 May 31, 2022
US8852636 May 31, 2022
US8858996 May 31, 2022
US9161920 May 31, 2022
US9198888 May 31, 2022
US9345695 May 31, 2022
US9707181 May 31, 2022

Dosage : Tablet, Delayed Release; Oral
Company : Horizon Medicines Llc
Ingredients : Esomeprazole Magnesium; Naproxen
Treatment : Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis
ANDA Filing Companies :

Vimpat
Lacosamide

Sales:
€ 1.1 billion (2018)

More information about this Drug

Patents Expiration Date
USRE38551 March 17, 2022

Dosage : Tablet; Oral
Company : Ucb Inc
Ingredients : Lacosamide
Treatment : Epilepsy and Partial-onset Seizures
ANDA Filing Companies : Alembic,  Amneal,  Aurobindo,  Breckenridge,  Glenmark,  Hetero,  Mylan,  Sandoz,  Sun (Ranbaxy),  Teva,  Watson,  Zydus Cadila

Conclusion

Gathering information is one thing and using it is another. Finding such lists on internet is easy but generating generic versions is not cakewalk. There still lies threats and hurdles which a generic company will face depending on the drug they choose for the generic version. 

But there is not much to fret about. With a proper threat analysis, developing a generic version should not give you nightmares anymore. How to go about it? Well, that’s what we are here for. For starters, get in touch by filling the short form below and our team will reach out to you in no time.

Authored by: Divya Goyal, Team Lead, Life Science Team, and Madan Ekhande, Research Analyst, Life Science Team

56 drug patents expiring in 2020 2021 2022

Leave a Comment

Contact Us

Got Questions! Queries! Send us an email.

Not readable? Change text. captcha txt
Share via
Copy link
Powered by Social Snap